RecruitingNCT07119411

ICU Background Early Awareness for Critical deterioratiON

ICU Background Early Awareness for Critical deterioratiON (BEACON)

Sponsor

ETH Zurich

Enrollment

1,962 participants

Start Date

Dec 1, 2025

Study Type

OBSERVATIONAL

Conditions

Mortality Respiratory Failure Organ Failure, Multiple Circulatory Failure Organ Dysfunction

Summary

The study will compare ICU sub-units, those with additional support of a clinician awareness system, ICU Beacon, and those receiving the standard of care. The win-ratio composite outcome will be assessed by comparing patients by study group and stratified by APACHE score at admission.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying ICU Beacon for people with circulatory failure, mortality, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERICU Beacon

Availability of a proprietary clinician awareness for potential organ deterioration software to treating clinicians (ICU Beacon) in addition to the standard of care.

Locations(1)

Inselspital - Universitätsspital Bern

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07119411

Related Trials

Real-Time Algorithm-Driven Ventilation Feedback to Improve Lung-Protective Ventilation in Patients With ARDS (REALVENT-study)

NCT073070661 location

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

NCT0606650233 locations